MedPath

Mechanistic and clinical effects of the regulation of inhibitory control networks via real-time fMRI neurofeedback in smokers

Not Applicable
Recruiting
Conditions
Smokers
Registration Number
DRKS00027056
Lead Sponsor
niversitätsklinikum der RWTH Aachen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Smoke more 10 cigarettes per day for at least 1 year
- Good German knowledge

Exclusion Criteria

- Severe psychiatric disease
- MR contraindications
- Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in inhibitory control performance as measured by Stop Signal task before and after neurofeedback session, using repeated measure ANOVA with the factors ‘Group’ (neurofeedback experimental condition, neurofeedback sham condition) and ‘Time’ (Pre-neurofeedback, Post-neurofeedback)
Secondary Outcome Measures
NameTimeMethod
- Neurofeedback specific changes in functional connectivity of the target network<br>- Changes in nicotine consumption and impulsivity trait, measured by Fagerstrom Test for Nicotine Dependence (FTND), Barratt Impulsiveness Scale (BIS-11), and UPPS Impulsive Behavior Scale in initial and follow-up (4 weeks later) assessment<br>- Transient changes in resting-state connectivity, measured before and after neurofeedback session?
© Copyright 2025. All Rights Reserved by MedPath